Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Heart Failure × Trastuzumab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 101 Stomach Neoplasms 17 HER2-positive Breast Cancer 13 Neoplasms 11 Neoplasm Metastasis 9 Colorectal Neoplasms 9 Esophageal Neoplasms 7 Triple Negative Breast Neoplasms 4 Meningeal Neoplasms 4 Colonic Neoplasms 4 Brain Neoplasms 4 Adenocarcinoma Of Esophagus 4 Salivary Gland Neoplasms 3 Rectal Neoplasms 3 Meningeal Carcinomatosis 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 Gallbladder Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Biliary Tract Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Solid Tumors 2 Prostatic Neoplasms 2 Pathologic Complete Response 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Inflammatory Breast Neoplasms 2 Hematologic Neoplasms 2 HER2-positive Gastric Cancer 2

Interventions

Standard of Care 2 Rituximab 2 Nutrition Assessment 2 Lenalidomide 2 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 pegfilgrastim 1 obinutuzumab 1 empagliflozin 1 dapagliflozin 1 acalabrutinib 1 Vincristine 1 Vascular Stiffness 1 Valsartan 1 Trastuzumab 1 Specimen Handling 1 Pulse Wave Analysis 1 Prednisolone 1 Practice Guidelines as Topic 1 Palliative Care 1 Ogivri 1 Mesenchymal Stem Cell Transplantation 1 Health Information Exchange 1 Exercise 1 Eplerenone 1 Electronic Health Records 1 Electrocardiography 1 Echocardiography 1 Doxorubicin 1 Dexrazoxane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04680442 2025-04-06

SCHOLAR-2

Population Health Research Institute

Phase 2 Recruiting

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡